| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,411 | 1,694 | 20,190 | 994 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 4,411 | 1,694 | 20,190 | 994 | | | Operating Expenses | | Research Development | 629 | 676 | 1,530 | 529 | | Selling General and Administrative | 2,141 | 2,017 | 5,220 | 3,083 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 88 | 94 | 94 | 184 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,553 | (1,093) | 13,346 | (2,802) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,218 | (2,686) | (2,124) | 2,450 | | Earnings Before Interest And Taxes | (242) | (3,779) | 11,222 | (776) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (242) | (3,779) | 11,222 | (776) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (242) | (3,779) | 11,222 | (776) | | | Non-recurring Events | | Discontinued Operations | (28) | (31) | (39) | (77) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (270) | (3,810) | 11,183 | (853) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($270) | ($3,810) | $11,183 | ($853) |
|
0.26% Nasdaq 
Income Statement
